Grow Therapy key facts
as of Oct 2026- Developer of a mental healthcare platform designed to connect individuals with licensed therapists and psychiatric providers.
- Grow Therapy is valued at approximately $3.0B as of Oct 2026 (last reported valuation).
- It has raised $328.1M; the latest was Later Stage VC ($150.0M) in Mar 2026.
- Notable investors include Sequoia Capital, Mana Ventures, Menlo Ventures, Village Global, Harvard Innovation Launch Lab — 36 tracked in total.
- Status: Privately Held (backing).
Grow Therapy's last reported valuation, Mar 2026. Nothing priced has surfaced since.
- ·The complete investor list: 36 names
- ·Watch Grow Therapy: the Monday email on marks, rounds and moves
Grow Therapy funding rounds
No funding rounds for Grow Therapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Grow Therapy
36+Grow Therapy valuation
Grow Therapy's last reported valuation was $3 billion in Mar 2026. No priced round, secondary trade or fund mark has surfaced since.
Grow Therapy investors
36 investors are on record for Grow Therapy, including Sequoia Capital, Mana Ventures, Menlo Ventures and Village Global. By type, the record holds 11 venture capital firms and 2 growth equity firms.
About Grow Therapy
Developer of a mental healthcare platform designed to connect individuals with licensed therapists and psychiatric providers. The company offers digital tools for provider matching, appointment scheduling, insurance verification, and practice management support, enabling patients to access therapy services and clinicians to manage their practice operations.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 120
- Website
- growtherapy.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.